SARA A OPENSHAW

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family MOUNTAIN GROVE, MO NPI 1467822650

General Payments — all program years on this page

$722.24

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 30
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $399.84 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $399.8416

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $249.458
Novo Nordisk AS $72.364
Exact Sciences Corporation $35.682
ABBVIE INC. $25.131
Lilly USA, LLC $17.221

By program year

Program yearAmountRecords
2023 $322.4014
2024 $399.8416

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100279936 Novo Nordisk Inc $23.11 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100312189 Novo Nordisk Inc $19.83 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100439323 Novo Nordisk Inc $15.01 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100459198 Novo Nordisk Inc $14.41 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104216265 AstraZeneca Pharmaceuticals LP $101.21 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104563472 AstraZeneca Pharmaceuticals LP $16.49 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104593240 AstraZeneca Pharmaceuticals LP $14.06 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104601526 AstraZeneca Pharmaceuticals LP $13.49 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104665207 AstraZeneca Pharmaceuticals LP $14.40 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105770216 AstraZeneca Pharmaceuticals LP $13.79 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105870869 AstraZeneca Pharmaceuticals LP $54.05 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105881624 AstraZeneca Pharmaceuticals LP $21.96 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107766096 ABBVIE INC. $25.13 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114417017 Exact Sciences Corporation $17.96 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114417021 Exact Sciences Corporation $17.72 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135937818 Lilly USA, LLC $17.22 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.